Literature DB >> 27729707

Seizures Following Cardiopulmonary Bypass.

Monique E Brouwer1, William J McMeniman1.   

Abstract

Seizures following cardiopulmonary bypass are an immediate and alarming indication that a neurologic event has occurred. A case report of a 67-year-old man undergoing aortic valve surgery who unexpectedly experiences seizures following cardiopulmonary bypass is outlined. Possible contributing factors including atheromatous disease in the aorta, low cerebral perfusion pressures, an open-chamber procedure, and the use of tranexamic acid are identified.

Entities:  

Keywords:  cardiopulmonary bypass; seizures; tranexamic acid

Mesh：

Substances：

Year:  2016        PMID： 27729707      PMCID： PMC5056684     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN： 0022-1058


  23 in total

1.  High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass.

Authors:  Dimitri Kalavrouziotis; Pierre Voisine; Siamak Mohammadi; Stephanie Dionne; Francois Dagenais
Journal:  Ann Thorac Surg       Date:  2011-11-04       Impact factor: 4.330

2.  The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines for Cardiopulmonary Bypass--Temperature Management During Cardiopulmonary Bypass.

Authors:  Richard Engelman; Robert A Baker; Donald S Likosky; Alina Grigore; Timothy A Dickinson; Linda Shore-Lesserson; John W Hammon
Journal:  Ann Thorac Surg       Date:  2015-08       Impact factor: 4.330

3.  Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery.

Authors:  Jeremiah R Brown; Nancy J O Birkmeyer; Gerald T O'Connor
Journal:  Circulation       Date:  2007-05-28       Impact factor: 29.690

4.  Bubble generation and venous air filtration by hard-shell venous reservoirs: a comparative study.

Authors:  S J Mitchell; T Willcox; D F Gorman
Journal:  Perfusion       Date:  1997-09       Impact factor: 1.972

5.  Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid(A) receptor antagonistic effect.

Authors:  Roman Furtmüller; Michael G Schlag; Michael Berger; Rudolf Hopf; Sigismund Huck; Werner Sieghart; Heinz Redl
Journal:  J Pharmacol Exp Ther       Date:  2002-04       Impact factor: 4.030

6.  Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators.

Authors:  G W Roach; M Kanchuger; C M Mangano; M Newman; N Nussmeier; R Wolman; A Aggarwal; K Marschall; S H Graham; C Ley
Journal:  N Engl J Med       Date:  1996-12-19       Impact factor: 91.245

7.  The association between tranexamic acid and convulsive seizures after cardiac surgery: a multivariate analysis in 11 529 patients.

Authors:  V Sharma; R Katznelson; A Jerath; L Garrido-Olivares; J Carroll; V Rao; M Wasowicz; G Djaiani
Journal:  Anaesthesia       Date:  2014-02       Impact factor: 6.955

8.  Improvement of outcomes after coronary artery bypass. A randomized trial comparing intraoperative high versus low mean arterial pressure.

Authors:  J P Gold; M E Charlson; P Williams-Russo; T P Szatrowski; J C Peterson; P A Pirraglia; G S Hartman; F S Yao; J P Hollenberg; D Barbut
Journal:  J Thorac Cardiovasc Surg       Date:  1995-11       Impact factor: 5.209

9.  Improvement of outcomes after coronary artery bypass II: a randomized trial comparing intraoperative high versus customized mean arterial pressure.

Authors:  Mary E Charlson; Janey C Peterson; Karl H Krieger; Gregg S Hartman; James P Hollenberg; William M Briggs; Alan Z Segal; Manish Parikh; Stephen J Thomas; Rebecca G Donahue; Mary Helen Purcell; Paul A Pirraglia; O Wayne Isom
Journal:  J Card Surg       Date:  2007 Nov-Dec       Impact factor: 1.620

10.  Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: incidence and clinical outcome.

Authors:  A Koster; J Börgermann; A Zittermann; J U Lueth; T Gillis-Januszewski; U Schirmer
Journal:  Br J Anaesth       Date:  2012-09-17       Impact factor: 9.166
View more
  1 in total

1.  Hydrogen-rich solution attenuates myocardial injury caused by cardiopulmonary bypass in rats via the Janus-activated kinase 2/signal transducer and activator of transcription 3 signaling pathway.

Authors:  Keyan Chen; Yingjie Sun; Yugang Diao; Tiezheng Zhang; Wanwei Dong
Journal:  Oncol Lett       Date:  2018-05-04       Impact factor: 2.967
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.